Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism

<table>CD86 positive cells evaluation in sciatic nerve. 14 days after CCI, 5 <i>μ</i>m sections of the formalin-fixed distal part of the sciatic nerve underwent immunohistochemical staining for CD86. Effect of PEA repeated treatments (30 mg kg<sup>−1</sup> s.c. daily) was evaluated in PPAR-<svg height="16.85" id="M48" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 29.275 16.85" width="29.275" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,16.588)"><path d="M545 106q-67 -118 -134 -118q-24 0 -40 37.5t-30 129.5h-2q-47 -72 -103 -119.5t-108 -47.5q-47 0 -76 45.5t-29 119.5q0 113 85 204t174 91q47 0 70 -33.5t43 -119.5h3q32 47 80 140l55 13l10 -9q-47 -80 -138 -201q17 -99 27.5 -136t22.5 -37q23 0 69 61zM333 204
q-14 98 -31 149.5t-50 51.5q-49 0 -94 -70t-45 -164q0 -55 15.5 -86t40.5 -31q70 0 164 150z" id="x1D6FC"></path></g>
<g transform="matrix(.012,-0,0,-.012,9.712,8.425)"><path d="M535 230h-212v-233h-58v233h-213v50h213v210h58v-210h212v-50z" id="x2B"></path></g><g transform="matrix(.012,-0,0,-.012,16.697,8.425)"><path d="M368 703l-264 -866h-60l265 866h59z" id="x2F"></path></g><g transform="matrix(.012,-0,0,-.012,21.599,8.425)"><path d="M535 230h-212v-233h-58v233h-213v50h213v210h58v-210h212v-50z" id="x2B"></path></g>
</svg> and in  <svg height="16.65" id="M49" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 22.450001 16.65" width="22.450001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.012,-0,0,-.012,2.9,8.425)"><path d="M535 230h-483v50h483v-50z" id="x2212"></path></g><g transform="matrix(.012,-0,0,-.012,9.885,8.425)"><path d="M368 703l-264 -866h-60l265 866h59z" id="x2F"></path></g><g transform="matrix(.012,-0,0,-.012,14.787,8.425)"><path d="M535 230h-483v50h483v-50z" id="x2212"></path></g>
</svg> mice, and representative images are showed, and a detailed image is shown in the insert. Original magnification 20x.</table>

Mediators of Inflammation

fig9

Figure 9

Figure 9: Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism 

Figure 9 | Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism 